Evaluating a new test for predicting colorectal adenoma recurrence
Official title: A Prospective Study to Assess the Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) in Predicting Colorectal Advanced Adenoma Recurrence
Run by Chinese University of Hong Kong · NCT05144152 · Data updated 2026-11-12
This study is testing a new test that looks at specific bacteria in the stool to see if it can better predict the return of advanced polyps in people who have had colon polyps before.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Shatin, New Territories) |
| Status | Recruiting |
| Started | December 13, 2021 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT05144152 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a known history of colorectal adenomas.
✕Probably not a fit
Patients with a personal history of colorectal cancer, polyposis syndrome, or inflammatory bowel disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the diagnostic accuracy of a novel panel of bacterial gene markers, referred to as M3, alongside the faecal immunochemical test (FIT) for detecting recurrent advanced adenomas in patients with a history of colonic adenomas. Given the limitations of FIT in identifying advanced adenomas, this observational study seeks to provide a more sensitive non-invasive alternative for early detection. Participants will undergo surveillance colonoscopy at regular intervals based on their adenoma history, and the effectiveness of M3 in conjunction with FIT will be evaluated. The study is particularly relevant in light of the rising incidence of colorectal cancer, especially among younger populations.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection of recurrent advanced adenomas, potentially reducing colorectal cancer mortality.
How similar studies have gone: Other studies have shown promise in using bacterial gene markers for colorectal cancer detection, indicating a potential for success in this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Known colorectal adenomas during index colonoscopy; 2. Available baseline M3 and FIT results before index colonoscopy; 3. Aged ≥18 years old; 4. Written informed consent obtained. Exclusion Criteria: 1. Refusal or unfit to undergo surveillance colonoscopy; 2. Incomplete colonoscopy, incomplete removal of colorectal adenomas, or inadequate bowel preparation (defined as Boston Bowel Preparation Scale score 0 or 1 in any colonic segment) at index colonoscopy; 3. Previous colonic resection; 4. Personal history of colorectal cancer; 5. Personal history of polyposis syndrome; 6. Personal history of inflammatory bowel disease; 7. Known pregnancy or lactation; 8. Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above);
Where it's running
-
Prince of Wales Hospital
Shatin, New Territories, Hong Kong Recruiting
Study contacts
- Study coordinator: Min Dai
- Email: mindai@link.cuhk.edu.hk
- Phone: +85260490760
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting recurrence of high-risk colorectal polyps using microbiota and metabolites
This study is trying to see if the bacteria and substances in the gut can help predict if high-risk colorectal polyps will come back after they've been removed.
-
Evaluating a computer-aided system for measuring colorectal polyp sizes
This study is testing a new computer program to see if it can measure the size of colorectal polyps more accurately during colonoscopy compared to traditional methods.
-
Non-invasive urine and stool tests for early colorectal cancer diagnosis
This study is testing if special urine and stool tests can help find colorectal cancer early in patients who have already had a positive blood test.
-
Using a microwave device to improve colonoscopy for detecting polyps
This study is testing a new microwave device during colonoscopies to see if it can help doctors find more polyps that might be missed with regular methods.
-
Comparing colonoscopy and stool testing for older adults with colon polyps
This study is testing whether a simple stool test can be just as effective as colonoscopy for monitoring older adults with a history of colon polyps.
-
New oral synbiotic formula to reduce colorectal adenoma recurrence
This study is testing a new oral formula made of probiotics and prebiotics to see if it can help prevent the return of certain growths in the colon after they've been removed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.